WaardeArticleFebruary2014.pdf (2.02 MB)
0/0

Information about medicines for patients in europe: To impede or to empower?

Download (2.02 MB)
conference contribution
posted on 16.09.2020 by Karel Van-Der-Waarde
Information about medicines in Europe does not really fulfil its potential. For patients, it is often very hard to understand and to apply information in a specific situation. For the pharmaceutical industry, it is hard to develop (writing-designing-testing) due to strict regulations. And for the Regulatory authorities, the current situation is hard to control and check. One of the main causes is that legal-, economic-, and health-criteria are simultaneously applied to information about medicines. However, these three criteria are fundamentally different, and have proved to be unbridgeable in the last 20 years. In order to provide patients with usable information, it seems essential to develop a legal system that is not based on standardization of processes and results, but instead is based on required performances in context.

History

School

  • Design and Creative Arts

Department

  • Design

Published in

Design, User Experience, and Usability. User Experience Design for Everyday Life Applications and Services

Pages

132 - 140

Source

International Conference of Design, User Experience, and Usability (DUXU 2014)

Publisher

Springer

Version

AM (Accepted Manuscript)

Rights holder

© Springer International Publishing Switzerland

Publisher statement

The final authenticated version is available online at https://doi.org/10.1007/978-3-319-07635-5_14.

Publication date

2014

Copyright date

2014

ISBN

9783319076348; 9783319076355

ISSN

0302-9743

eISSN

1611-3349

Book series

Lecture Notes in Computer Science; vol. 8519

Language

en

Editor(s)

Aaron Marcus

Location

Heraklion, Crete, Greece

Event dates

22nd June 2014 - 27th June 2014

Depositor

Dr Karel Van Der Waarde. Deposit date: 15 September 2020

Exports

Logo branding

Categories

Exports